VistaGen Therapeutics, Inc.

VTGN

NASDAQ

Healthcare

Biotechnology

South San Francisco, CA, US48 employeesvistagen.com

$0.59

-0.01(-1.78%)

Mkt Cap $19M

$0.51

$4.90

52-Week Range

At a Glance

AI-generated

Revenue breakdown: License (100%).

8-K

VistaGen Therapeutics, Inc. disclosed non-compliance with Nasdaq Listing Rule 5605(c)(2) as of April 1, 2026, following the resignation of director Mary Rotunno, reducing its Audit Committee to two members; the company has a cure period to regain compliance.

$19M

Market Cap

$613.0K

Revenue

-$52M

Net Income

Employees48

Fundamentals

How The Business Makes Money

Revenue by Segment

License100%($1M)

Activity

What Changed Recently

Delisting

Apr 1, 2026

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On April 1, 2026, Vistagen Therapeutics, Inc. (the “ Company

Management Change

Feb 19, 2026

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensation Arrangements of Certain Officers. On February 1

Delisting

Feb 5, 2026

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On February 3, 2026, Vistagen Therapeutics, Inc. (the “ Comp

Financial Results

Feb 11, 2026

Results of Operations and Financial Condition. On February 12, 2026, Vistagen Therapeutics, Inc. (the “ Company ”) issued a press release announcing financial r

Other Event

Mar 10, 2026

Other Events On March 5, 2026, Vistagen Therapeutics, Inc. (the “ Company ”) implemented a Board approved reduction in its workforce by approximately 20%. The r

Peer Companies

Company	Price	Change	Market Cap	P/E
IRDOpus Genetics, Inc.	$4.55	-2.99%	$324M	-57.6
ABOSAcumen Pharmaceuticals, I...	$2.70	+5.88%	$164M	-1.2
SPROSpero Therapeutics, Inc.	$2.44	-0.61%	$141M	-3.0
AGENAgenus Inc.	$3.33	-1.91%	$128M	1133.3
SEERSeer, Inc.	$1.71	+0.29%	$96M	-1.3
MCRBSeres Therapeutics, Inc.	$9.25	+4.43%	$89M	13.5
HURATuHURA Biosciences, Inc.	$1.41	-13.27%	$79M	-3.4
CGTXCognition Therapeutics, I...	$0.88	-1.84%	$64M	-3.1

Analyst View

Company Profile

CIK0001411685

ISINUS92840H4002

CUSIP92840H202

Phone650 577 3600

Address343 Allerton Avenue, South San Francisco, CA, 94080, US

SEC EDGAR